3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
5
Head & Neck
2
Genitourinary
2
Gastrointestinal
2
Breast
2
Sarcoma
1
Lymphoid
1
Gynecologic
1
Conditions
Lymphoma
2
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Mixed Dementias
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Lewy Body Disease
1
Kidney Neoplasms
1
Dementia, Vascular
1
Dementia
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Breast Neoplasms
1
Interventions
pembrolizumab
6
Magnetic Resonance Spectroscopy
5
Gemcitabine
4
Specimen Handling
3
Nivolumab
3
Drug Therapy
3
epacadostat
2
Therapeutics
2
Taxes
2
Sirolimus
2
Paclitaxel
2
Doxorubicin
2
Blood Specimen Collection
2
Biopsy
2
Azacitidine
2
vandetanib
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
toripalimab
1
temsirolimus
1
tanespimycin
1
spartalizumab
1
sargramostim
1
sapanisertib
1
romidepsin
1
relatlimab
1
pertuzumab
1
pegfilgrastim
1
palbociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Referral and Consultation
×
Lymphoid
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts